Third Wave Technologies, Inc.

Third Wave Technologies, Inc. — FDA 510(k) Submissions

Third Wave Technologies, Inc. has submitted 2 FDA 510(k) premarket notifications since 2005, of which 2 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Drug Metabolizing Enzyme Genotyping Systems, System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection . Use the specialty filter in the sidebar to narrow results.